AngioDynamics names Eric Honroth CEO, effective Nov. 2, 2026

• AngioDynamics named Eric Honroth president, CEO, board member, effective Nov. 2, 2026.
• Honroth previously served as global president, Life Science at Getinge.
• Jim Clemmer to leave the board on Nov. 2, 2026, shifting to a consulting role.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AngioDynamics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261008210859) on October 08, 2026, and is solely responsible for the information contained therein.